SeekingAlpha · Aug 11, 2026
Bionano Genomics, Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-08-11. The following slide deck was published by Bionano Genomics, Inc.
NYSE · BNGO
Bionano Genomics, Inc.
Healthcare · Medical - Diagnostics & Research
$1.17
Down-$0.04 (-3.31%)
Updated Aug 31, 2026, 10:32 AM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 5.48M
- P/E ratio
- -0.23
- Dividend yield
- 0.00%
- 52-week range
- $1.00 – $5.50
- Volume
- 179.63K
- Avg. volume
- 721.42K
Price performance
BNGO price history
1M range · 20 trading sessions · Daily adjusted prices
BNGO closed at $1.17 after 20 trading sessions, up 4.93% for the selected period.
- Last close
- $1.17
- Period change
- +4.93%
- Period low
- $1.07
- Period high
- $1.25
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $1.23 | $1.24 | $1.16 | $1.17 | 179.63K |
| Aug 27, 2026 | $1.21 | $1.25 | $1.20 | $1.21 | 168.13K |
| Aug 26, 2026 | $1.24 | $1.26 | $1.205 | $1.21 | 157.09K |
| Aug 25, 2026 | $1.22 | $1.26 | $1.201 | $1.25 | 115.65K |
| Aug 24, 2026 | $1.22 | $1.25 | $1.18 | $1.22 | 133.38K |
| Aug 21, 2026 | $1.22 | $1.26 | $1.18 | $1.20 | 193.21K |
| Aug 20, 2026 | $1.22 | $1.24 | $1.19 | $1.21 | 111.53K |
| Aug 19, 2026 | $1.18 | $1.25 | $1.18 | $1.23 | 245.82K |
| Aug 18, 2026 | $1.21 | $1.21 | $1.14 | $1.18 | 180.74K |
| Aug 17, 2026 | $1.17 | $1.21 | $1.1538 | $1.19 | 126.26K |
| Aug 14, 2026 | $1.18 | $1.19 | $1.13 | $1.18 | 84.48K |
| Aug 13, 2026 | $1.20 | $1.2023 | $1.15 | $1.18 | 164.84K |
| Aug 12, 2026 | $1.19 | $1.20 | $1.17 | $1.20 | 77.26K |
| Aug 11, 2026 | $1.16 | $1.19 | $1.1218 | $1.19 | 133.12K |
| Aug 10, 2026 | $1.16 | $1.195 | $1.14 | $1.16 | 242.54K |
| Aug 7, 2026 | $1.12 | $1.16 | $1.10 | $1.16 | 78.65K |
| Aug 6, 2026 | $1.11 | $1.115 | $1.095 | $1.10 | 60.57K |
| Aug 5, 2026 | $1.12 | $1.125 | $1.07 | $1.07 | 78.04K |
| Aug 4, 2026 | $1.13 | $1.145 | $1.11 | $1.12 | 111.44K |
| Aug 3, 2026 | $1.08 | $1.14 | $1.0718 | $1.115 | 303.59K |
Latest BNGO news
The latest Smart Investors Daily articles mentioning BNGO.
Stock researchCompany · Overview
BNGO research
Overview
Company profile and research snapshot.
Company profile
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $46.50
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Apr 13, 2026 | HC Wainwright & Co. | Buy | — |
| Nov 24, 2025 | HC Wainwright & Co. | Buy | — |
| Aug 18, 2025 | HC Wainwright & Co. | Buy | — |
| May 20, 2025 | Maxim Group | Buy | — |
| Apr 9, 2025 | HC Wainwright & Co. | Buy | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Aug 10, 2026
Bionano Genomics, Inc. (BNGO) Q2 2026 Earnings Call Transcript
Bionano Genomics, Inc. (BNGO) Q2 2026 Earnings Call August 10, 2026 4:30 PM EDTCompany ParticipantsAlbert Luderer - Chairman, Interim CEO, Interim President...
Benzinga · Aug 10, 2026
Bionano Genomics Raises FY2026 Sales Guidance from $30.000M-$33.000M to $31.000M-$33.000M vs $32.137M Est
Bionano Genomics (NASDAQ:BNGO) raises FY2026 sales outlook from $30.000 million-$33.000 million to $31.000 million-$33.000 million vs $32.137 million estimate.
Benzinga · Aug 10, 2026
Bionano Genomics Sees Q3 Sales $8.200M-$8.600M vs $8.575M Est
Bionano Genomics (NASDAQ:BNGO) sees Q3 sales of $8.200 million-$8.600 million vs $8.575 million analyst estimate.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
